Fruta Planta and Reduce Weight Fruta Planta have been voluntarily recalled because they contain sibutramine, a medication that was taken off the market because of a significantly increased risk of cardiovascular events and strokes. Sibutramine, an oral anorexiant (appetite suppressant), was withdrawn from the US, UK, EU, Australian, Canadian, Hong Kong, Thai and Mexican markets for the same safety reasons.
According to the Food and Drug Administration, several reports have been received of adverse events linked to Fruta Planta and Reduce Fruta Planta use, including a sizeable number of cardiac events, and even one fatality.
The sibutramine in the Fruta Planta products may raise blood pressure and/or heart rate, presenting a serious risk for those with a history of coronary artery disease, congestive heart failure, stroke or arrhythmias. Sibutramine can also interact with other medications, with serious, and even fatal consequences, the FDA informs.
If you have bought any of the recalled products you should stop consuming them immediately, the FDA has announced. If you have taken the product and experience any negative side effects, see your doctor straight away.
Throw the product away in a sealed container so that other humans, as well as pets and animals are not at risk, or return it to the company.
You may contact the company by telephone on 877-225-1009 (Monday to Friday, 10am to 4.30pm).
The FDA encourages both patients and health care professionals to report adverse events related to these recalled products to the MedWatch Safety Information and Adverse Event Reporting Program.
Both products - Reduce Weight Fruta Planta and Fruta Planta - come in 30-capsule boxes. They are sold online.
Source:FDA
Written by Christian Nordqvist
Copyright: Medical News Today
Not to be reproduced without permission of Medical News Today
Note: Any medical information published on this website is not intended as a substitute for informed medical advice and you should not take any action before consulting with a health care professional. For more information, please read our terms and conditions.
All opinions are moderated before being added.
Please note that we publish your name, but we do not publish your email address. It is only used to let you know when your message is published. We do not use it for any other purpose. Please see our privacy policy for more information.
If you write about specific medications or operations, please do not name health care professionals by name.
Contact Our News Editors
For any corrections of factual information, or to contact the editors please use our feedback form.
Please send any medical news or health news press releases to:
No comments:
Post a Comment